isoniazid has been researched along with cc 3052 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ehrt, S; Fallows, D; Kaplan, G; Koo, MS; Manca, C; Muller, G; O'Brien, P; Subbian, S; Sung, N; Tsenova, L; Yang, G | 1 |
Fallows, D; Kaplan, G; Koo, MS; Muller, G; O'Brien, P; Peixoto, B; Subbian, S; Tsenova, L; Yang, G; Zeldis, JB | 1 |
Dartois, V; Fallows, D; Kaplan, G; Koo, MS; Muller, G; O'Brien, P; Peixoto, B; Subbian, S; Tsenova, L; Yang, G | 1 |
3 other study(ies) available for isoniazid and cc 3052
Article | Year |
---|---|
Phosphodiesterase 4 inhibition reduces innate immunity and improves isoniazid clearance of Mycobacterium tuberculosis in the lungs of infected mice.
Topics: Animals; Antibiotics, Antitubercular; Bacterial Load; Cyclic Nucleotide Phosphodiesterases, Type 4; Disease Models, Animal; Down-Regulation; Drug Evaluation, Preclinical; Drug Interactions; Immunity, Innate; Isoniazid; Lung; Metabolic Clearance Rate; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Mycobacterium tuberculosis; Phosphodiesterase 4 Inhibitors; Thalidomide; Tuberculosis | 2011 |
Phosphodiesterase-4 inhibition combined with isoniazid treatment of rabbits with pulmonary tuberculosis reduces macrophage activation and lung pathology.
Topics: Animals; Antitubercular Agents; Blotting, Western; Colony-Forming Units Assay; Cyclic Nucleotide Phosphodiesterases, Type 4; Cytokines; Drug Synergism; Drug Therapy, Combination; Female; Isoniazid; Lung; Macrophage Activation; Male; Matrix Metalloproteinases; Mycobacterium tuberculosis; Phosphodiesterase 4 Inhibitors; Pulmonary Fibrosis; Rabbits; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thalidomide; Tuberculosis, Pulmonary | 2011 |
Phosphodiesterase-4 inhibition alters gene expression and improves isoniazid-mediated clearance of Mycobacterium tuberculosis in rabbit lungs.
Topics: Animals; Antitubercular Agents; Bacterial Load; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Drug Resistance, Bacterial; Female; Gene Expression Regulation; Isoniazid; Lung; Macrophages; Male; Mycobacterium tuberculosis; Oligonucleotide Array Sequence Analysis; Phosphodiesterase 4 Inhibitors; Rabbits; Thalidomide; Tuberculosis; Tumor Necrosis Factor-alpha | 2011 |